INTRODUCTION
============

Most thyroid diseases, including autoimmune thyroiditis and thyroid cancer, have been recognized to have high heritability \[[@B1][@B2]\]. In twin studies, a high concordance rate for Graves\' disease (GD) in monozygotic twins was reported, in the range of 50% to 70%, compared with 3% to 25% in dizygotic twins \[[@B1][@B3]\]. A study of autoimmune hypothyroidism likewise showed a 55% concordance in monozygotic twins \[[@B4]\]. Familial clustering of autoimmune thyroid disease has been consistently reported \[[@B5][@B6][@B7]\]. Hemminki et al. \[[@B7]\] showed that the familial standardized incidence ratios for GD were 4.49 for individuals with an affected parent, 5.04 for those whose singleton sibling was affected, 310 when two or more siblings were affected, and 16.45 in twins. For Hashimoto\'s thyroiditis (HT), the sibling risk ratio was 28 based on data from the National Health and Nutrition Examination Survey III \[[@B8]\], and a similar risk was confirmed in data from Germany \[[@B5]\]. These pieces of evidence suggest the existence of a genetic predisposition to autoimmune thyroid diseases.

Thyroid function, including levels of thyroid hormone and thyroid stimulating hormone (TSH), is regulated within a narrow range in individuals, although the inter-individual variability is large \[[@B9]\]. This suggests that every individual has his or her own set point of thyroid function \[[@B10]\]. About 40% to 60% of variation in thyroid function has been estimated to be determined by genetic factors \[[@B10][@B11][@B12]\]. Thyroid cancers also show a high degree of heritability, with genetic factors accounting for more than 50% of the causes of thyroid cancer \[[@B2]\]. Except for medullary thyroid cancer, which is well known to be caused by germline or somatic mutations, the prevalence of familial differentiated thyroid cancer (DTC) accounted for 2.5% to 11.3% cases of DTC \[[@B13][@B14][@B15][@B16][@B17]\]. Only 5% of cases of nonmedullary familial DTC were reported to be of the syndromic form, which is accompanied by well-known germline mutations, including Cowden syndrome, familial adenomatous polyposis, Gardner syndrome, Carney complex type 1, Werner syndrome, and DICER1 syndrome \[[@B18]\]. Thus, the majority of cases of familial DTC were found not to be caused by germline mutations, despite its pattern of genetic inheritance.

Thus, genetics plays a prominent role in most thyroid-related phenotypes. Research into the genes responsible for thyroid disease has identified several candidates \[[@B19]\]. However, candidate gene studies have been controversial and have shown very few reproducible findings. Panicker \[[@B19]\] published a thorough review of genetic studies of thyroid function and autoimmune thyroid diseases conducted through 2010. In the last decade, genome-wide association studies (GWAS) have been extensively used to identify genes involved in complex diseases \[[@B20]\]. GWAS have facilitated the screening of a large proportion of the genome and discovered a variety of susceptibility genes. GWAS have been widely applied in autoimmune thyroid diseases, thyroid function, and thyroid cancer, and have identified susceptibility genes for thyroid-related phenotypes. Herein, we comprehensively review the wide range of discoveries from GWAS conducted in Western and Asian populations regarding autoimmune diseases, thyroid function, and thyroid cancer.

GWAS FOR AUTOIMMUNE THYROID DISEASES
====================================

Several candidate gene studies identified putative susceptibility variants for GD, but only the human leukocyte antigen (*HLA*) locus and the cytotoxic T-lymphocyte associated protein 4 (*CTLA4*), thyroid stimulating hormone receptor (*TSHR*), and protein tyrosine phosphatase, non-receptor type 22 (*PTPN22*) loci were confirmed in subsequent replication studies \[[@B21][@B22][@B23][@B24][@B25]\]. The first genome-wide analysis using 14,436 nonsynonymous single-nucleotide polymorphisms (SNPs) for GD was performed by the Wellcome Trust Case Control Consortium, and showed that three loci (*HLA*, *TSHR*, and Fc receptor like 3 \[*FCRL3*\]) were associated with GD \[[@B26]\]. A subsequent GWAS with \>500,000 SNPs confirmed previously reported loci and identified a novel region of susceptibility loci at 6q27 (the ribonuclease T2 \[*RNASET2*\]-FGFR1 oncogene partner \[*FGFR1OP*\]-CCR6) and an intergenic region at 4p14 (GDCG4p14) \[[@B27]\]. Several GWAS of autoimmune thyroid diseases (GD, HT, and positivity of anti-thyroid peroxidase \[TPO\] antibody or anti-thyroglobulin \[Tg\] antibody) and hypothyroidism have further identified susceptibility loci ([Table 1](#T1){ref-type="table"}) \[[@B26][@B27][@B28][@B29][@B30][@B31][@B32][@B33][@B34][@B35][@B36]\]. Since GWAS of HT have been performed for a variety of phenotypes including self-reported hypothyroidism, biochemical hypothyroidism with positive antibodies, antibody positivity, and level of antibodies, caution is needed when interpreting the results. Several types of hypothyroidism might not have an autoimmune etiology, and autoimmunity does not necessarily lead to hypothyroidism. Thus, careful consideration regarding the phenotype is required when interpreting the biological mechanisms of the associated genes identified through GWAS of autoimmune thyroid diseases.

A heterogeneity analysis between GD and HT showed that GD and HT share several susceptibility loci (*HLA*, *PTPN22*, and *CTLA4*), while an association with *TSHR* was exclusively seen in GD patients. The majority of genes associated with autoimmune thyroid disease are thought to play a major role in autoimmune processes, including disrupted T-cell regulation and peripheral immune tolerance \[[@B37]\]. Variants in thyroid-specific loci, including *TSHR* and forkhead box E1 (*FOXE1*), could affect the immune recognition of autoantigens and antibody generation \[[@B37]\].

GWAS OF THYROID FUNCTION
========================

Thyroid function, including levels of free thyroxine (T4) and TSH, is highly heritable even in euthyroid subjects. A large meta-analysis of GWAS of serum levels of TSH and free T4, in 26,420 and 17,520 euthyroid European individuals, respectively, was performed, identifying many susceptibility loci for levels of TSH (phosphodiesterase 8B \[*PDE8B*\], phosphodiesterase 10A \[*PDE10A*\], capping actin protein of muscle Z-line subunit beta \[*CAPZB*\], *MAP*, vascular endothelial growth factor A \[*VEGFA*\], nuclear receptor subfamily 3 group C member 2 \[*NR3C2*\], insulin like growth factor binding protein 5 \[*IGFBP5*\], SRY-box 9 \[*SOX9*\], nuclear factor I A \[*NFIA*\], fibroblast growth factor 7 \[*FGF7*\], PR/SET domain 11 \[*PRDM11*\], microRNA 1179 \[*MIR1179*\], insulin receptor \[*INSR*\], *ABO*, inositol-tetrakisphosphate 1-kinase \[*ITPK1*\], neuregulin 1 \[*NRG1*\], MAP3K12 binding inhibitory protein 1 \[*MBIP*\], SAM and SH3 domain containing 1 \[*SASH1*\], and GLIS family zinc finger 3 \[*GLIS3*\]) and levels of free T4 (iodothyronine deiodinase 1 \[*DIO1*\], LIM homeobox 3 \[*LHX3*\], *FOXE1*, aminoadipate aminotransferase \[*AADAT*\], lysophosphatidylcholine acyltransferase 2 \[*LPCAT2*\]/calpain small subunit 2 \[*CAPNS2*\], neuropilin and tolloid like 1 \[*NETO1*\]/F-box protein 15 \[*FBXO15*\]) \[[@B38]\]. A GWAS of TSH levels was also conducted in 1,346 Chinese Han individuals \[[@B39]\]. Zhan et al. \[[@B39]\] confirmed previously reported TSH susceptibility loci near *FOXE1* and *CAPZB* and identified novel variants in XK related 4 (*XKR4*). Whole-genome sequence-based analysis was performed to examine the genetic architecture for levels of free T4 and TSH, and further identified novel variants on synapsin II (*SYN2*), *PDE8B*, and beta-1,4-galactosyltransferase 6 (*B4GALT6*) \[[@B40]\]. They also found a rare functional variant (minor allele frequency=0.4%) in the transthyretin (*TTR*) gene, which is located near *B4GALT6*. This study showed that common variants explained over 20% of the variance in TSH and free T4 and that a substantial amount of heritability of thyroid function could be explained by rare variants with larger effects. Results of GWAS for thyroid function are summarized in [Table 2](#T2){ref-type="table"}.

Thyroid function may be affected by the presence of antibodies to TPO or Tg, even in the normal range. In GWAS of thyroid function, data on the presence of antibodies were limited. Therefore, it is difficult to conclude that the genes found in GWAS of thyroid function determine an individual set point of the hypothalamus-pituitary-thyroid axis. Several genetic loci identified in GWAS of thyroid function were also found in GWAS of autoimmune thyroid diseases (*FOXE1*, *CAPZB*, and *PDE8B*). A detailed examination of the presence of antibodies should be considered when performing GWAS of thyroid function in the future. In addition, only very limited GWAS of thyroid function have been performed in Asians, so more research is needed.

GWAS OF THYROID CANCER
======================

The first GWAS of thyroid cancer was reported in 2009 and showed that common variants located on 9q22.33 (*FOXE1*) and 14q13.3 (NK2 homeobox 1 \[*NKX2-1*\]) were associated with DTC \[[@B41]\]. Associations at *FOXE1*, *MBIP/NKX2-1*, disrupted in renal carcinoma 3 (*DIRC3*), and NRG1 have been identified and repeatedly confirmed in individuals of European ancestry \[[@B41][@B42][@B43][@B44]\]. Several markers associated with DTC, including inner mitochondrial membrane peptidase subunit 2 (*IMMP2L*), retinoic acid receptor responder 1 (*RARRES1*), small nuclear RNA activating complex polypeptide 4 (*SNAPC4*), basic leucine zipper ATF-like transcription factor (*BATF*), DEAH-box helicase 35 (*DHX35*), UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4 (*GALNTL4*), 5-hydroxytryptamine receptor 1B (*HTR1B*), forkhead box A2 (*FOXA2*), and WDR11 antisense RNA 1 (*WDR11-AS1*), were identified but not replicated in other studies \[[@B43][@B44][@B45][@B46]\]. A recent meta-analysis of GWAS including a total of 3,001 DTC patients and 287,550 controls from five study groups of European populations found five novel loci (pecanex-like 2 \[*PCNXL2*\], telomerase RNA component \[*TERC*\], neuronal regeneration related protein \[*NREP*\]-erythrocyte membrane protein band 4.1 like 4A \[*EPB41L4A*\], oligosaccharide-binding folds containing 1 \[*OBFC1*\], and SMAD family member 3 \[*SMAD3*\]) \[[@B47]\]. [Table 3](#T3){ref-type="table"} provides the susceptibility loci identified in GWAS of thyroid cancer \[[@B38][@B39][@B40][@B48][@B49]\]. The most robust signals were detected on 9q22.33 (*FOXE1*) in Caucasians \[[@B41][@B50]\]. The *FOXE1* locus was also reported to be a susceptibility gene for radiation-related thyroid cancer \[[@B50]\]. A functional study showed that common variants on *FOXE1* regulated *FOXE1* transcription through the recruitment of the upstream stimulatory factor 1 (USF1)/USF2 transcription factors \[[@B51]\]. Several reports demonstrated that variants of *FOXE1* were related to aspects of the clinical aggressiveness of papillary thyroid cancer (PTC), such as tumor stage, size, lymphocytic infiltration, and extrathyroidal extension \[[@B52][@B53]\].

Recently, we reported 15 variants from 11 loci associated with DTC in a Korean GWAS including 1,085 cases of DTC and 8,884 controls \[[@B54]\]. The most robust signals were detected in the *NRG1* gene, and expression quantitative trait loci analysis showed that variants on *NRG1* were also associated with *NRG1* expression in thyroid tissues \[[@B54]\]. He et al. \[[@B55]\] also showed that the expression levels of *NRG1* isoforms were significantly correlated with genotypes. *NRG1* encodes neuregulin-1, which acts on the erb-b2 receptor tyrosine kinase (ERBB) family of tyrosine kinase receptors. In a study of the intrinsic resistance of PTC to a B-Raf inhibitor, ERBB2/ERBB3 activation was found to be dependent on autocrine production of neuregulin-1 \[[@B56]\]. *NRG1* dysregulation is also closely related with the phosphoinositide 3-kinase (PI3K)-AKT and mitogen-activated protein kinase (MAPK) signaling pathway via ERBB \[[@B57]\]. Our gene set enrichment analysis data showed that variants on *NRG1* were associated with many pathways related to cellular growth or cancer, and the ERBB-MAPK signaling pathway was the most significantly enriched. This evidence indicates that *NRG1* expression in thyroid tissue could contribute to increased DTC risk via ERBB signaling.

Our results confirmed previously reported loci (*FOXE1*, *NKX2-1*, *DIRC3*, and *PCNXL2*) from GWAS of European populations and found novel susceptibility loci (vav guanine nucleotide exchange factor 3 \[*VAV3*\], INSR, MRSB3, fragile histidine triad \[*FHIT*\], septin 11 \[*SEPT11*\], and solute carrier family 24 member A6 \[*SLC24A6*\]) associated with DTC. Specially, a variant of *SLC24A6* was associated with a specific risk of follicular thyroid cancer, for which the genetic factors that increase the risk of thyroid cancer may vary depending on the cancer subtype. Signals on *VAV3*, *INSR*, *MRSB3*, *FHIT*, *SEPT11*, and *SLC24A6* were only identified in Koreans, suggesting between-study heterogeneity in GWAS of DTC.

In GWAS in European and Korean populations, some genetic loci (*FOXE1*, *NKX2-1*, *DIRC3*, *NRG1*, and *PCNXL2*) were commonly found, while certain susceptibility loci were only found in either the European or Korean population. In addition, the risk allele frequency of commonly found SNPs differs by race, and the DTC risk by genotype varies across ethnicities. For example, the risk allele frequencies of variants on *FOXE1* were reported to be 0.14 to 0.34 in Europeans and 0.08 to 0.13 in Asians, suggesting ethnic differences in allele frequencies and a small genetic contribution of variants on *FOXE1* to the development of DTC in East Asians \[[@B58]\]. Moreover, common variants on *FOXE1* were associated with an increased risk of DTC, with an odds ratio (OR) of 1.80 in the European population, but the OR was 1.35 in East Asians \[[@B58]\]. A comparison of these associations, including effect size (OR) and *P* values, between Europeans and Koreans is shown in [Fig. 1](#F1){ref-type="fig"} \[[@B54]\].

CONCLUSIONS
===========

Twin and family studies of autoimmune thyroid diseases and thyroid cancer have indicated high heritability, suggesting that genetic factors play a key role in disease onset. Previous candidate-gene studies have limitations, such as lack of reproducibility and small sample sizes with limited statistical power. In the last decade, GWAS have unraveled the many forms of genetic predisposition to autoimmune thyroid disease, thyroid function, and thyroid cancer. These genetic discoveries provide insight into the pathogenesis of these diseases and provide opportunities to develop new therapies.
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![Comparison of associations between Europeans and Koreans. The *P* values for differentiated thyroid cancer (DTC) between Koreans (x-axis) and Europeans (y-axis) are plotted with the corresponding Korean effect sizes (odd ratio \[OR\]). The *P* value shows the −log~10~ scale, and the *P* values of novel single-nucleotide polymorphisms from this study are compared as unknown. Adapted from Son et al. \[[@B54]\]. *FOXE1*, forkhead box E1; *DIRC3*, disrupted in renal carcinoma 3; *NKX2-1*, NK2 homeobox 1; *NRG1*, neuregulin 1; *DHX35*, DEAH-box helicase 35; *IMMP2L*, inner mitochondrial membrane peptidase subunit 2; *ARSB*, arylsulfatase B; *WDR11-AS1*, WDR11 antisense RNA 1; *VAV3*, vav guanine nucleotide exchange factor 3; *PCNXL2*, pecanex-like 2; *MSRB3*, methionine sulfoxide reductase B3; *SEPT11*, septin 11; *FHIT*, fragile histidine triad; *INSR*, insulin receptor.](enm-33-175-g001){#F1}

###### Susceptibility Loci for Autoimmune Thyroid Disease Detected by Genome-Wide Association Studies

![](enm-33-175-i001)

  Phenotypes      Locus           Gene                  Protein function                                                                               Population             Reference
  --------------- --------------- --------------------- ---------------------------------------------------------------------------------------------- ---------------------- ------------------------------
  GD, HT          1p13            *PTPN22*              Involvement in T-cell signaling                                                                UK, USA                \[[@B28][@B30]\]
  GD              10p15.1         *IL2RA*               Encoding CD25                                                                                  UK                     \[[@B28]\]
  GD, HT          2q33.2          *CTLA4*               Inhibition of T-cell signaling                                                                 UK, Chinese Han, USA   \[[@B27][@B28][@B30][@B31]\]
  GD              1q23.1          *FCRL3*               Regulation of B-cell signaling                                                                 UK, Chinese Han        \[[@B26][@B27][@B28][@B31]\]
  GD, HT          6p21            HLA class I region    Endogenous antigen presentation for recognition by CD8+ T-cells                                UK, Chinese Han, USA   \[[@B26][@B27][@B30][@B31]\]
  GD, HT          6p21            HLA class II region   Exogenous antigen presentation for recognition by CD4+ T-helper cells                          UK, Chinese Han, USA   \[[@B26][@B27][@B30][@B31]\]
  GD              14q31.1         *TSHR*                Autoantigenic target in GD                                                                     UK, Chinese Han        \[[@B26][@B27][@B28][@B31]\]
  GD, HT          6q27            *RNASET2-FGFR1OP*     A fusion partner for FGFR1 in the t(6;8) (q27;p11) translocations                              UK, Chinese Han        \[[@B27][@B28][@B31]\]
  GD              4p14            *CHRNA9-RHOH*         Negative regulator of hematopoietic cell growth and survival                                   Chinese Han            \[[@B27][@B31]\]
  GD              1p36.32         *MMEL1*               Role in pain perception, arterial pressure regulation, phosphate metabolism, and homeostasis   UK                     \[[@B28]\]
  GD              12q12           *PRICKLE1*            Negative regulator of the Wnt/β-catenin signaling pathway                                      UK                     \[[@B28]\]
  GD              16p11.2         *ITGAM*               Role in leukocyte adhesion to platelets and fibrinogen                                         UK                     \[[@B28]\]
  GD              Xq21.1          *GPR174-ITM2A*        Thymocyte selection and T-cell activation                                                      Chinese Han            \[[@B31][@B32]\]
  GD              22q12.3--13.1   *C1QTNF6-RAC2*        Role in elicitation of immune responses and the induction of peripheral immune tolerance       Chinese Han            \[[@B31]\]
  GD              1q23.2          *SLAMF6*              Coreceptor in the process of NK cell activation                                                Chinese Han            \[[@B31]\]
  GD              9q34.2          *ABO*                 Determination of ABO blood group                                                               Chinese Han            \[[@B31]\]
  GD              14q32.          *C14orf64*            Long intergenic non-protein coding RNA 1550 (LINC01550)                                        Chinese Han            \[[@B31]\]
  GD              8q24.22         *TG*                  Encoding thyroglobulin                                                                         Chinese Han            \[[@B31]\]
  HT              9q22.33         *FOXE1*               Encoding TTF-2, role in thyroid morphogenesis                                                  USA                    \[[@B29][@B30]\]
  HT              12q24.12        *SH2B3*               Negative regulator of cytokine signaling                                                       USA                    \[[@B30]\]
  HT              1p13.3          *VAV3*                Role in actin cytoskeletal rearrangements and transcriptional alterations                      US, Japan              \[[@B30][@B36]\]
  HT              1p36.13         *CAPZB*               Role in regulating actin filament dynamics                                                     USA                    \[[@B30]\]
  HT              5q13.3          *PDE8B*               Role in hydrolysis of the second messenger cAMP                                                USA                    \[[@B30]\]
  GD, HT          2p25.1          *TRIB2*               Role in apoptosis of hematopoietic cells                                                       UK                     \[[@B28]\]
  GD, HT          3q27.3          *LPP*                 Involvement in cell-cell adhesion and cell motility                                            UK                     \[[@B28]\]
  GD, HT, TPOAb   6q15            *BACH2*               Role in coordinating transcription activation and repression by MAFK                           UK, European^a^        \[[@B28][@B34]\]
  GD, HT          11q21           *FAM76B*              Role in NEDD8-specific protease activity                                                       UK                     \[[@B28]\]
  TPOAb           2p25.3          *TPO*                 Encoding thyroid peroxidase                                                                    European, Korea        \[[@B33][@B34]\]
  TPOAb           12q24.12        *ATXN2*               Role in Akt signaling and checkpoint regulation.                                               European               \[[@B34]\]
  TPOAb           1p13.2          *MAGI3*               Role in Sertoli-Sertoli cell junction dynamics and Ras signaling pathway                       European               \[[@B34]\]
  TPOAb           3q21.1          *KALRN*               Role in p75 NTR-mediated signaling and EPH-ephrin signaling                                    European               \[[@B34]\]
  TPOAb           9q31.1          *GRIN3A*              Role in circadian entrainment                                                                  Croatia                \[[@B35]\]
  TgAb            6q27            *DLL1*                Role in mediating cell fate decisions during hematopoiesis                                     Croatia                \[[@B35]\]

GD, Graves\' disease; HT, Hashimoto\'s thyroiditis or hypothyroidism; *PTPN22*, protein tyrosine phosphatase, non-receptor type 22; *IL2RA*, interleukin 2 receptor subunit alpha; *CTLA4*, cytotoxic T-lymphocyte associated protein 4; *FCRL3*, Fc receptor like 3; HLA, human leukocyte antigen; *TSHR*, thyroid stimulating hormone receptor; *RNASET2*, ribonuclease T2; *FGFR1OP*, FGFR1 oncogene partner; FGFR1, fibroblast growth factor receptor 1; *CHRNA9*, cholinergic receptor nicotinic alpha 9 subunit; *RHOH*, ras homolog family member H; *MMEL1*, membrane metalloendopeptidase like 1; *PRICKLE1*, prickle planar cell polarity protein 1; *ITGAM*, integrin subunit alpha M; *GPR174*, G protein-coupled receptor 174; *ITM2A*, integral membrane protein 2A; *C1QTNF6*, C1q and TNF related 6; *RAC2*, Rac family small GTPase 2; *SLAMF6*, SLAM family member 6; NK, natural killer; *TG*, anti-thyroglobulin; *FOXE1*, forkhead box E1; TTF-2, thyroid transcription factor-2; *SH2B3*, SH2B adaptor protein 3; *VAV3*, vav guanine nucleotide exchange factor 3; *CAPZB*, capping actin protein of muscle Z-line subunit beta; *PDE8B*, phosphodiesterase 8B; cAMP, cyclic adenosine monophosphate; *TRIB2*, tribbles pseudokinase 2; *LPP*, LIM domain containing preferred translocation partner in lipoma; TPOAb, anti-thyroid peroxidase antibody; *BACH2*, BTB domain and CNC homolog 2; MAFK, MAF bZIP transcription factor K; *FAM76B*, family with sequence similarity 76 member B; NEDD8, neural precursor cell expressed, developmentally down-regulated 8; *TPO*, anti-thyroid peroxidase; *ATXN2*, ataxin 2; *MAGI3*, membrane associated guanylate kinase, WW and PDZ domain containing 3; *KALRN*, kalirin RhoGEF kinase; NTR, neurotrophin receptor; *GRIN3A*, glutamate ionotropic receptor NMDA type subunit 3A; TgAb, anti-thyroglobulin antibody; *DLL1*, delta like canonical Notch ligand 1.

^a^European refers to European ancestry from various countries.

###### Susceptibility Loci for Levels of Thyroid Stimulating Hormone or Free Thyroxine Detected by Genome-Wide Association Studies
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  Phenotypes   Locus             Gene                                                                          Protein function                                  Population                     Reference
  ------------ ----------------- ----------------------------------------------------------------------------- ------------------------------------------------- ------------------------------ ------------------------------
  TSH          5q13.3            *PDE8B*                                                                       Role in hydrolysis of the second messenger cAMP   European, USA, Germany, UK     \[[@B38][@B40][@B48][@B49]\]
  6q27         *PDE10A*          Role in regulation of the intracellular concentration of cyclic nucleotides   European, UK                                      \[[@B38][@B40]\]               
  1p36.13      *CAPZB*           Regulating actin filament dynamics                                            European, Chinese Han, Germany, UK                \[[@B38][@B39][@B40][@B49]\]   
  16q23.2      *MAF*             Role in increased T-cell susceptibility to apoptosis                          European, UK, Germany                             \[[@B38][@B40][@B49]\]         
  6p21.1       *VEGFA*           Proliferation and migration of vascular endothelial cells                     European, UK                                      \[[@B38][@B40]\]               
  4q31.23      *NR3C2*           Role in aldosterone actions                                                   European, Germany, UK                             \[[@B38][@B40][@B49]\]         
  2q35         *IGFBP5*          Encoding insulin like growth factor binding protein 5                         European                                          \[[@B38]\]                     
  17q24.3      *SOX9*            Role in chondrocyte differentiation                                           European                                          \[[@B38]\]                     
  1p31.3       *NFIA*            Encoding nuclear factor IA                                                    European                                          \[[@B38]\]                     
  15q21.2      *FGF7*            Mitogenic and cell survival activities                                        European                                          \[[@B38]\]                     
  11p11.2      *PRDM11*          Role in transcription regulation                                              European                                          \[[@B38]\]                     
  15q26.1      *MIR1179*         MicroRNA 1179                                                                 European                                          \[[@B38]\]                     
  19p13.2      *INSR*            Encoding insulin receptor                                                     European                                          \[[@B38]\]                     
  9q34.2       *ABO*             Determination of ABO blood group                                              European, UK                                      \[[@B38][@B40]\]               
  14q32.12     *ITPK1*           Regulation of the synthesis of inositol tetraphosphate                        European                                          \[[@B38]\]                     
  8p12         *NRG1*            Role in the growth and development of multiple organ systems                  European                                          \[[@B38]\]                     
  14q13.3      *MBIP-NKX2-1*     Encoding TTF-1, binding to TG promoter                                        European, UK                                      \[[@B38][@B40]\]               
  6q24.3       *SASH1*           Role in the TLR4 signaling pathway                                            European                                          \[[@B38]\]                     
  9p24.2       *GLIS3*           Role in transcription in thyroid gland                                        European                                          \[[@B38]\]                     
  8q12.1       *XKR4*            Role in apoptosis                                                             Chinese Han                                       \[[@B39]\]                     
  9q22.33      *FOXE1*           Encoding TTF-2, role in thyroid morphogenesis                                 Chinese Han, USA, UK                              \[[@B39][@B40][@B48]\]         
  2q35         *IGFBP2*          Encoding insulin like growth factor binding protein 2                         UK                                                \[[@B40]\]                     
  3p25.2       *SYN2*            Binding to small synaptic vesicles                                            UK                                                \[[@B40]\]                     
  Free T4      1p32.3            *DIO1*                                                                        Encoding iodothyronine deiodinase 1               European, UK                   \[[@B38][@B40]\]
  9q34.3       *LHX3*            Role in pituitary development                                                 European, UK                                      \[[@B38][@B40]\]               
  9q22.33      *FOXE1*           Encoding TTF-2, role in thyroid morphogenesis                                 European                                          \[[@B38]\]                     
  4q33         *AADAT*           Role in L-lysine catabolism                                                   European, UK                                      \[[@B38][@B40]\]               
  16q12.2      *LPCAT2-CAPNS2*   Role in membrane biogenesis                                                   European                                          \[[@B38]\]                     
  18q22.3      *NETO1-FBXO15*    Role in spatial learning and memory in the hippocampus                        European                                          \[[@B38]\]                     
  18q12.1      *B4GALT6*         Role in biosynthesis of glycosphingolipids                                    UK                                                \[[@B40]\]                     

TSH, thyroid stimulating hormone; *PDE8B*, phosphodiesterase 8B; cAMP, cyclic adenosine monophosphate; *PDE10A*, phosphodiesterase 10A; *CAPZB*, capping actin protein of muscle Z-line subunit beta; *VEGFA*, vascular endothelial growth factor A; *NR3C2*, nuclear receptor subfamily 3 group C member 2; *IGFBP5*, insulin like growth factor binding protein 5; *SOX9*, SRY-box 9; *NFIA*, nuclear factor I A; *FGF7*, fibroblast growth factor 7; *PRDM11*, PR/SET domain 11; *MIR1179*, microRNA 1179; *INSR*, insulin receptor; *ITPK1*, inositol-tetrakisphosphate 1-kinase; *NRG1*, neuregulin 1; *MBIP*, MAP3K12 binding inhibitory protein 1; *NKX2-1*, NK2 homeobox 1; TTF, thyroid transcription factor; TG, thyroglobulin; *SASH1*, SAM and SH3 domain containing 1; TLR4, Toll-like receptor 4; *GLIS3*, GLIS family zinc finger 3; *XKR4*, XK related 4; *FOXE1*, forkhead box E1; *IGFBP2*, insulin like growth factor binding protein 2; *SYN2*, synapsin II; T4, thyroxine; *DIO1*, iodothyronine deiodinase 1; *LHX3*, LIM homeobox 3; *AADAT*, aminoadipate aminotransferase; *LPCAT2*, lysophosphatidylcholine acyltransferase 2; *CAPNS2*, calpain small subunit 2; NETO1, neuropilin and tolloid like 1; *FBXO15*, F-box protein 15; *B4GALT6*, beta-1,4-galactosyltransferase 6.

###### Susceptibility Loci for Thyroid Cancer Detected by Genome-Wide Association Studies
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  Locus      Gene            Protein function                                                                                  Population                                                        References
  ---------- --------------- ------------------------------------------------------------------------------------------------- ----------------------------------------------------------------- ------------------------------------------------------
  9q22.33    *FOXE1*         Encoding TTF-2, role in thyroid morphogenesis                                                     Iceland, USA, Spain, Netherlands, Belarus, Italy, Poland, Korea   \[[@B41][@B42][@B46][@B47][@B48][@B49][@B50][@B54]\]
  14q13.3    *MBIP-NKX2-1*   Encoding TTF-1                                                                                    Iceland, USA, Spain, Netherlands, Italy, Poland, Korea            \[[@B41][@B42][@B46][@B47][@B54]\]
  2q35       *DIRC3*         Non-coding RNA                                                                                    Iceland, USA, Spain, Netherlands, Italy, Poland, UK, Korea        \[[@B42][@B43][@B47][@B54]\]
  8p12       *NRG1*          Role in the growth and development of multiple organ systems                                      Iceland, USA, Spain, Netherlands, Korea                           \[[@B42][@B54]\]
  7q31.1     *IMMP2L*        Catalytic activity of the mitochondrial inner membrane peptidase complex                          Italy, Poland, UK, Spain                                          \[[@B43]\]
  3q25.32    *RARRES1*       Encoding a type 1 membrane protein.                                                               Italy, Poland, UK, Spain                                          \[[@B43]\]
  9q34       *SNAPC4*        Role in RNA polymerase II and III transcription from small nuclear RNA promoters.                 Italy, Poland, UK, Spain                                          \[[@B43]\]
  14q24.3    *BATF*          Negative regulator of AP-1/ATF transcriptional events                                             Italy, Poland                                                     \[[@B44]\]
  20q11.23   *DHX35*         Putative RNA helicases                                                                            Italy, Poland                                                     \[[@B44]\]
  5q14       *ARSB*          Role in the regulation of cell adhesion, cell migration and invasion                              Italy, Poland, Spain                                              \[[@B44]\]
  13q12      *SPATA13*       Role in regulation of cell migration and adhesion assembly and disassembly                        Italy, Poland, Spain                                              \[[@B44]\]
  11p15.3    *GALNTL4*       Role in initial reaction in O-linked oligosaccharide biosynthesis                                 Italy, Poland, Spain                                              \[[@B45]\]
  20p11      *FOXA2*         Activators for liver-specific genes such as albumin and transthyretin                             Italy, Poland, Spain                                              \[[@B45]\]
  10q26.12   *WDR11-AS1*     Non-coding RNA                                                                                    Italy, Spain                                                      \[[@B46]\]
  6q14.1     *HTR1B*         Role in activity of adenylate cyclase and the release of serotonin, dopamine, and acetylcholine   Italy, Spain                                                      \[[@B46]\]
  1q42.2     *PCNXL2*        Role in tumorigenesis                                                                             Iceland, USA, Spain, Netherlands, Korea                           \[[@B47][@B54]\]
  10q24.33   *OBFC1*         Role in initiation of DNA replication                                                             Iceland, USA, Spain, Netherlands                                  \[[@B47]\]
  5q22.1     NREP-EPB41L4A   Role in interactions between the cytoskeleton and plasma membrane                                 Iceland, USA, Spain, Netherlands                                  \[[@B47]\]
  15q22.33   *SMAD3*         Signal transducers and transcriptional modulator                                                  Iceland, USA, Spain, Netherlands                                  \[[@B47]\]
  3q26.2     *TERC-LRRC34*   Encoding telomerase RNA component                                                                 Iceland, USA, Spain, Netherlands                                  \[[@B47]\]
  5p15.33    *TERT*          Encoding telomerase reverse transcriptase                                                         Iceland, USA, Spain, Netherlands                                  \[[@B47]\]
  12q14.3    *MSRB3*         Role in reduction of methionine sulfoxide to methionine                                           Korea                                                             \[[@B54]\]
  1p13.3     *VAV3*          Role in actin cytoskeletal rearrangements and transcriptional alterations                         Korea                                                             \[[@B54]\]
  4q21.1     *SEPT11*        Role in cytokinesis and vesicle trafficking                                                       Korea                                                             \[[@B54]\]
  3p14.2     *FHIT*          Role in purine metabolism                                                                         Korea                                                             \[[@B54]\]
  19p13.2    *INSR*          Encoding insulin receptor                                                                         Korea                                                             \[[@B54]\]
  12q24.13   *SLC24A6*       Role in cellular calcium homeostasis                                                              Korea                                                             \[[@B54]\]

*FOXE1*, forkhead box E1; TTF, thyroid transcription factor; *MBIP*, MAP3K12 binding inhibitory protein 1; *NKX2-1*, NK2 homeobox 1; *DIRC3*, disrupted in renal carcinoma 3; *NRG1*, neuregulin 1; *IMMP2L*, inner mitochondrial membrane peptidase subunit 2; *RARRES1*, retinoic acid receptor responder 1; *SNAPC4*, small nuclear RNA activating complex polypeptide 4; *BATF*, basic leucine zipper ATF-like transcription factor; AP-1, activator protein 1; ATF, activating transcription factor; *DHX35*, DEAH-box helicase 35; *ARSB*, arylsulfatase B; *SPATA13*, spermatogenesis associated 13; *GALNTL4*, UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 4; *FOXA2*, forkhead box A2; *WDR11-AS1*, WDR11 antisense RNA 1; *HTR1B*, 5-hydroxytryptamine receptor 1B; *PCNXL2*, pecanex-like 2; *OBFC1*, oligosaccharide-binding folds containing 1; *NREP*, neuronal regeneration related protein; *EPB41L4A*, erythrocyte membrane protein band 4.1 like 4A; *SMAD3*, SMAD family member 3; *TERC*, telomerase RNA component; *LRRC34*, leucine rich repeat containing 34; *TERT*, telomerase reverse transcriptase; *MSRB3*, methionine sulfoxide reductase B3; *VAV3*, vav guanine nucleotide exchange factor 3; *SEPT11*, septin 11; *FHIT*, fragile histidine triad; *INSR*, insulin receptor; *SLC24A6*, solute carrier family 24 member A6.
